Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 13
(2)
◽
pp. 150-155
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 77
(2)
◽
pp. 339-347
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):